IL4 and cancer: Cancer cells highly expressing IL4 and IL13 receptors can be targeted by interleukins conjugated to Pseudomonas exotoxin or targeted doxorubicin liposomes (Kawakami et al., 2002a,b; Kioi et al., 2005; Suzuki et al., 2015).